Introduction

The Even Briefer Assessment Scale for Depression (EBAS-D) is an ultra-brief screening instrument developed to rapidly identify depressive symptoms in clinical practice and research. Its concise format minimizes respondent burden while providing a practical method for detecting individuals who may require further psychological evaluation. The scale is particularly useful in primary care, hospitals, community settings, and large epidemiological studies where administration time is limited. The original document describes the EBAS-D as a short, reliable, and valid tool for depression screening.

Description

The EBAS-D consists of a small number of items that assess the core symptoms of depression. Participants rate their recent experiences using a standardized response scale, and the responses are combined into an overall depression score.

Its brevity allows rapid administration without substantially compromising psychometric quality, making it suitable for routine screening and repeated assessments.

Purpose

The EBAS-D is designed to:

  • Rapidly screen for depressive symptoms.
  • Identify individuals who may require comprehensive clinical evaluation.
  • Monitor symptom changes during treatment or follow-up.
  • Reduce assessment time in busy healthcare settings.
  • Support depression research involving large populations.

Administration

The questionnaire is completed by the respondent and generally requires only a few minutes to administer. Standardized instructions should be used to ensure consistent data collection across participants.

Scoring

Responses are assigned numerical values according to the instrument’s response scale and summed to produce a total score. Higher scores indicate greater severity of depressive symptoms.

Researchers should follow the official scoring guidelines for the validated version being used.

Interpretation

The EBAS-D is intended as a screening instrument, not a diagnostic tool. Elevated scores indicate an increased likelihood of depression and should be interpreted together with clinical interviews, medical history, and additional psychological assessments.

Statistical Analysis

The EBAS-D supports several psychometric analyses, including:

  • Descriptive statistics (mean, standard deviation, score distribution).
  • Internal consistency (Cronbach’s alpha or McDonald’s omega).
  • Construct validity through correlations with other depression measures.
  • Criterion validity using ROC analysis to evaluate sensitivity, specificity, and optimal cut-off scores.
  • Group comparisons using t-tests, ANOVA, or non-parametric alternatives when appropriate.

Applications

The EBAS-D is suitable for:

  • Clinical psychology
  • Psychiatry
  • Primary healthcare
  • Hospital screening
  • Public health research
  • Epidemiological surveys
  • Intervention and treatment outcome studies

Advantages

  • Very short administration time.
  • Easy to score and interpret.
  • Suitable for repeated measurements.
  • Reduces respondent burden.
  • Appropriate for large research samples.

Limitations

As with all self-report measures, responses may be influenced by social desirability, recall bias, or current emotional state. The EBAS-D should therefore be used as an initial screening tool and not as a substitute for a comprehensive clinical assessment.

References

The original document recommends validating the EBAS-D against established depression measures such as the Beck Depression Inventory (BDI) and the Patient Health Questionnaire-9 (PHQ-9), while evaluating reliability and diagnostic accuracy through validation studies.